Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.95
-0.59 (-7.82%)
At close: Mar 10, 2025, 4:00 PM
6.91
-0.04 (-0.53%)
After-hours: Mar 10, 2025, 8:00 PM EST
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Ginkgo Bioworks Holdings stock have an average target of 17.25, with a low estimate of 7.00 and a high estimate of 40. The average target predicts an increase of 148.20% from the current stock price of 6.95.
Analyst Consensus: Sell
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for Ginkgo Bioworks Holdings stock from 5 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 7 | 7 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | +43.88% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | +0.72% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | +72.66% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | +15.11% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
181.18M
from 227.04M
Decreased by -20.20%
Revenue Next Year
216.26M
from 181.18M
Increased by 19.36%
EPS This Year
-7.44
from -10.54
EPS Next Year
-5.90
from -7.44
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 211.4M | 277.1M | 348.9M |
| Avg | 181.2M | 216.3M | 266.5M |
| Low | 168.4M | 176.9M | 191.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.9% | 52.9% | 61.3% |
| Avg | -20.2% | 19.4% | 23.2% |
| Low | -25.8% | -2.4% | -11.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -6.31 | -4.46 |
| Avg | -7.44 | -5.90 |
| Low | -9.00 | -8.06 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.